Is it time for a new yellow fever vaccine? (Q37802642)

23 August 2017

title

Is it time for a new yellow fever vaccine? (English)

1 reference

23 August 2017

0 references

1 reference

Edward B Hayes

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

3 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

28

1 reference

23 August 2017

issue

51

1 reference

23 August 2017

page(s)

8073-8076

1 reference

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Acute viscerotropic disease following vaccination against yellow fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Viscerotropic disease following yellow fever vaccination in Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Adverse event reports following yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Vaccine policy changes and epidemiology of poliomyelitis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Anaphylaxis from yellow fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Short report: Incidence of yellow fever vaccine-associated neurotropic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Prevention of yellow fever in persons traveling to the tropics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Congenital yellow fever virus infection after immunization in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

7 January 2021

A YELLOW FEVER VACCINE

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Pressure-inactivated yellow fever 17DD virus: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Role of injectable and oral polio vaccines in polio eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Theoretical impact of an anti-HCV vaccine on the annual number of liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Potential public health impact of new tuberculosis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

Yellow fever vaccination: how much is enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

A Case of Yellow Fever Vaccine-Associated Viscerotropic Disease in Ecuador

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.015

10.1016/J.VACCINE.2010.10.015

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference